EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 21-Jun-2026 15:15 ET (21-Jun-2026 19:15 GMT/UTC)

11-Feb-2026

Does a past abortion or miscarriage affect a woman’s risk of developing breast cancer?

A prior abortion or miscarriage was not linked with an increased risk of developing pre- or postmenopausal breast cancer in a study published in Acta Obstetricia et Gynecologica Scandinavica.

Journal: Acta Obstetricia Et Gynecologica Scandinavica

11-Feb-2026

Could a treatment redirect the body’s anti-viral immune response to target cancer cells?

Wiley
Peer-Reviewed Publication

Because many different types of cancer cells overexpress programmed death-ligand 1 (PD-L1), this cell surface protein is a major target of cancer immunotherapy. Unfortunately, drugs that target it do not trigger especially strong anti-cancer immune responses. New research published in Advanced Science reveals a promising strategy that harnesses pre-existing antiviral immunity to boost anti-tumor responses.

Journal: Advanced Science

10-Feb-2026

Biomarkers predict patients with glioblastoma who will survive longer after treatment with cancer-targeting virus

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

Glioblastoma is a deadly brain cancer that suppresses the immune system and doesn’t respond well to available therapies

Researchers engineered a cancer-targeting virus that can be injected directly in glioblastoma tumors

Adding an immune booster to the virus increased the length of survival in a subset of patients and helped identify blood biomarkers in patients most likely to benefit

Journal: Clinical Cancer Research

10-Feb-2026

Growth of spreading pancreatic cancer fueled by 'under-appreciated' epigenetic changes

Johns Hopkins Medicine
Peer-Reviewed Publication

In a lab-grown cell study focused on potential new treatment targets for halting the spread of most pancreatic cancers, Johns Hopkins Medicine scientists report they have found that a gene called KLF5 (Krueppel-like factor 5) fuels the growth of such spreading tumors not by acquiring abnormal changes in the cancer cells’ DNA code itself but by altering chemical changes and organization of DNA, or epigenetics, that turns genes on and off

Journal: Molecular Cancer
Funder: National Institutes of Health, Celgene License Pathway Agreement, A gift from the friends and family of Jasmine Lampadarios.

10-Feb-2026

University of South Alabama Research named Top 10 Scientific Breakthroughs of 2025

University of South Alabama
Grant and Award Announcement

Dr. Simon Grelet, with the University of South Alabama's Mitchell Cancer Institute, has identified a novel mechanism by which neurons transfer mitochondria — the cell’s energy-producing structures — to cancer cells. This interaction fuels cancer metastasis and opens new possibilities for therapeutic intervention.

10-Feb-2026

UCalgary study investigates the use of a common vitamin to treat the aggressive brain cancer glioblastoma

University of Calgary
Peer-Reviewed Publication

University of Calgary researchers have designed a study to investigate whether high doses of vitamin B3 or niacin could rejuvenate compromised immune cells to kill glioblastoma tumour cells. The clinical trial was designed to determine the maximum dose and potential benefit of controlled-release niacin that could be added to the recommended chemotherapy and radiotherapy treatments.

Journal: Neuro-Oncology
Funder: Alberta Cancer Foundation, Canadian Institutes of Health Research

10-Feb-2026

New nanoparticles enable melanoma tumors to be removed with low-power laser light

Oregon State University
Peer-Reviewed Publication

Researchers at Oregon State University have developed and tested in a mouse model a new type of nanoparticle that enables the removal of melanoma tumors with a low-power laser.

Journal: Advanced Functional Materials
Funder: Eunice Kennedy Shriver National Institute of Child Health and Human Development

10-Feb-2026

GLP-1 receptor agonists plus progestins and endometrial cancer risk in nonmalignant uterine diseases

JAMA Network
Peer-Reviewed Publication

About The Study: In this cohort study of women with benign uterine pathology or endometrial hyperplasia, combined glucagon-like peptide-1 receptor agonist (GLP-1RA) and progestin was associated with reduced endometrial cancer risk. Further investigation is warranted to assess its applicability and underlying mechanisms.

Journal: JAMA Network Open

10-Feb-2026

Discovery of unique brain tumor subtypes offers hope for targeted glioma therapies

The Hospital for Sick Children
Peer-Reviewed Publication

SickKids researchers identify three subtypes of high-grade gliomas with distinct treatment responses to provide precision care for patients.

Journal: Nature Genetics

10-Feb-2026

University of Missouri conducts first in-person clinical trial for nuclear medicine breakthrough device

University of Missouri-Columbia
Business Announcement

In a major leap for cancer care at the University of Missouri, the School of Medicine and MU Health Care have launched their first clinical trial using a leading-edge therapy manufactured on campus at the university’s research reactor. The achievement also showcases the breadth of research capabilities across campus to bring a radiopharmaceutical from development, through testing, to human clinical trials.